Dublin, Dec. 11, 2020 (GLOBE NEWSWIRE) -- The "Lung Cancer Surgery - Global Market Trajectory & Analytics" report has been added to ResearchAndMarkets.com's offering.
The publisher brings years of research experience to the 6th edition of this report. The 277-page report presents concise insights into how the pandemic has impacted production and the buy side for 2020 and 2021. A short-term phased recovery by key geography is also addressed.
Global Lung Cancer Surgery Market to Reach $37.4 Billion by 2027
Amid the COVID-19 crisis, the global market for Lung Cancer Surgery estimated at US$25.5 Billion in the year 2020, is projected to reach a revised size of US$37.4 Billion by 2027, growing at a CAGR of 5.6% over the period 2020-2027.
Thoracotomy, one of the segments analyzed in the report, is projected to record 5.4% CAGR and reach US$26.2 Billion by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the Minimally Invasive Surgeries segment is readjusted to a revised 6.2% CAGR for the next 7-year period.
The U.S. Market is Estimated at $6.9 Billion, While China is Forecast to Grow at 8.5% CAGR
The Lung Cancer Surgery market in the U.S. is estimated at US$6.9 Billion in the year 2020. China, the world`s second largest economy, is forecast to reach a projected market size of US$7.8 Billion by the year 2027 trailing a CAGR of 8.5% over the analysis period 2020 to 2027. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 3.1% and 5% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 3.5% CAGR.
Competitors identified in this market include, among others:
- Accuray, Inc.
- Ackermann Instrumente GmbH
- AngioDynamics, Inc.
- Ethicon US LLC
- Intuitive Surgical, Inc.
- Karl Storz GmbH & Co. KG
- Olympus Corporation
- Scanlan International, Inc.
- Teleflex, Inc.
- Trokamed GmbH
Key Topics Covered:
I. INTRODUCTION, METHODOLOGY & REPORT SCOPE
II. EXECUTIVE SUMMARY
1. MARKET OVERVIEW
- Global Competitor Market Shares
- Lung Cancer Surgery Competitor Market Share Scenario Worldwide (in %): 2019 & 2025
- Impact of Covid-19 and a Looming Global Recession
2. FOCUS ON SELECT PLAYERS
3. MARKET TRENDS & DRIVERS
4. GLOBAL MARKET PERSPECTIVE
III. MARKET ANALYSIS
IV. COMPETITION
- Total Companies Profiled: 46
For more information about this report visit https://www.researchandmarkets.com/r/bh92xs
Research and Markets also offers Custom Research services providing focused, comprehensive and tailored research.